Physician
Andrew C. Ip, M.D.
According to 2025 Medicare claims, Andrew Ip, M.D. (NPI: 1306102934) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07601-2105. Ip is affiliated with the Emory Healthcare Network Advantage (ACO ID: A4771), participating under the MSSP model.
Ip's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 288 traditional Medicare patients, billed 30,166 HCPCS/CPT codes, and received $245,112 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 836 prescription claims across 161 beneficiaries totaling $2,034,379 in drug costs, led by Calquence (Acalabrutinib Maleate). Open Payments data shows 49 records totaling $131,503. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $961 to $245,112. Similarly, Part D prescription costs have risen steadily, from $8,897 to $2,034,379. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.